Public Sector Pension Investment Board Aurinia Pharmaceuticals Inc. Transaction History

Public Sector Pension Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $3.14 Million - $6.76 Million	-286,953 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$10.0 - $14.52 $91,600 - $133,003	-9,160 Reduced 3.09%	286,953 $3.72 Million
Q1 2021 May 14, 2021	SELL	$12.3 - $18.73 $105,780 - $161,078	-8,600 Reduced 2.82%	296,113 $3.85 Million
Q4 2020 Feb 12, 2021	SELL	$12.94 - $16.05 $58,061 - $72,016	-4,487 Reduced 1.45%	304,713 $4.2 Million
Q3 2020 Nov 13, 2020	BUY	$13.19 - $16.66 $510,453 - $644,742	38,700 Added 14.31%	309,200 $4.54 Million
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $3.82 Million - $4.96 Million	270,500 New	270,500 $4.4 Million

211

58.4M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.17B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.